Related content

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

By Li Sophia   Kaur Primal   Chan Virginia   Berney Steven  

Clinical Rheumatology, Vol. 28, Iss. 7, 2009-07 ,pp. : 787-791

Springer Publishing Company

Access to resources Recommend Favorite

Association Between Polymorphism of Tumor Necrosis Factor-α Promoter and Response to Lamivudine Treatment in Patients with Chronic Hepatitis B

By Park Yong   Lee Jung   Kim Do   Chang Hye   Kim Ja   Lee Chun   Park Jun   Ahn Sang   Lee Kwan   Han Kwang  

Digestive Diseases and Sciences, Vol. 55, Iss. 7, 2010-07 ,pp. : 2043-2048

Springer Publishing Company

Access to resources Recommend Favorite

Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion

By Kuo Yuan-Hung   Chen Chien-Hung   Wang Jing-Houng   Hung Chou-Hung   Tseng Po-Lin   Lu Sheng-Nan   Changchien Chi-Sin   Lee Chuan-Mo  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 1, 2010-01 ,pp. : 75-81

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of tumour necrosis factor-α in patients with chronic hepatitis C infection

By Zavos C.   Kountouras J.   Zavos N.   Chatzopoulos D.  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 283-283

Springer Publishing Company

Access to resources Recommend Favorite

Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy

By  

Current Rheumatology Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 157-165

Bentham Science Publishers

Access to resources Recommend Favorite